(Q35186746)

7 August 2017

1 reference

title

Ductal carcinoma in situ with microinvasion (English)

1 reference

7 August 2017

1 reference

Tara L Adamovich

1

1 reference

7 August 2017

Rache M Simmons

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

The American Journal of Surgery

7 August 2017

published in

1 reference

7 August 2017

volume

186

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

112-116

1 reference

Microinvasive carcinoma (T1mic) of the breast: clinicopathologic profile of 21 cases

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Ductal carcinomain situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Axillary node status in nonpalpable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Management of in situ and minimally invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Lymph node metastasis from ductal carcinoma in situ with microinvasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Mammary ductal carcinoma in situ with microinvasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Radical surgery and conservative treatment of ductal carcinoma in situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Intraductal carcinoma of the breast. (1960-1969)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2803%2900166-1

10.1016/S0002-9610(03)00166-1

7 January 2021

Identifiers

DOI

1 reference

release_z56rgkcvhjg6xi7ny7hc6e5spq

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z56rgkcvhjg6xi7ny7hc6e5spq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference